Any current/future new fundraising through debt or equity?

There is no mention of any current or future fundraising through debt or equity in the provided transcript. The company is focusing on preserving money within the company for business expansion rather than major investments aimed at tax savings. Capex plans are primarily related to Greenfield expansion of the H-acid plant (costing around Rs. 55-60 Crores) and further expansion of Pigment Green, depending on market demand. No firm investment plans beyond existing ongoing projects for FY2020 were indicated. No explicit references to raising funds via debt or equity were discussed during the call

Any current/future capex/capital investment/strategic investment?

Current ongoing projects: - Specialty chemical product precipitated silica at Dahej, capacity 10,000 metric tonnes per annum, commercial production expected from Q2 FY2020. - Pigment Green expansion completed; further expansion planned depending on market demand. Future capex plans: - No firm investment plans beyond current projects for FY2020, except for Pigment Green expansion. - Potential for Greenfield expansion of H-acid capacity estimated to cost around Rs. 55-60 Crores. Strategy: - Focus on expanding H-acid capacity if market demand stabilizes. - Gradual capacity utili

Future growth expectations in sales/revenue/volumes?

Volumes showed growth with Q3 FY2019 at 2,355 MT versus 1,843 MT in Q3 FY2018, indicating sustained demand. CPC Green capacity expanded from 1,920 MT to 2,400 MT; full utilization expected by end of FY2020. Precipitated silica product commercialization expected from Q2 FY2020, with revenues starting from Q3 FY2020 in the local market. H-acid capacity utilization aimed to stabilize above 50%-60% in the current quarter with further market acceptance in export markets expected over next 2-3 quarters. Pigment Green expansion planned, dependent on market conditions, targeting approx. 20-25% capacit

Future growth expectations in earnings/operating earnings/profits/EPS?

H-acid production issues have been resolved; normalized production and quality expected from Q4 FY2019, leading to improved margins and profits. Normal EBITDA margins for core chemical business (Vinyl Sulphone and Pigment Green) expected in range of 12%-15%. H-acid expected to contribute positively to both topline and bottomline from next quarter, likely breakeven at PBT level soon. Capacity expansions underway: - CPC Green capacity increased; full utilization expected by end of FY2020. - Precipitated silica commercial production expected from Q2 FY2020 with revenue contribution starting

AksharChem (I)Q3 FY19Chemicals & Petrochemicals

AksharChem (I) Q3 FY19 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹414.7P/E: 26.9Market Cap: ₹333 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3

Volumes showed growth with Q3 FY2019 at 2,355 MT versus 1,843 MT in Q3 FY2018, indicating sustained demand.
CPC Green capacity expanded from 1,920 MT to 2,400 MT; full utilization expected by end of FY2020.
Precipitated silica product commercialization expected from Q2 FY2020, with revenues starting from Q3 FY2020 in the local market.
H-acid capacity utilization aimed to stabilize above 50%-60% in the current quarter with further market acceptance in export markets expected over next 2-3 quarters.
Pigment Green expansion planned, dependent on market conditions, targeting approx. 20-25% capacity addition quarterly.
Overall company sales growth driven by higher volumes and better realizations; raw material prices expected to stabilize.
Long-term potential for increased market share from China's controlled capacity and environmental constraints.

Margin guidance

Category 3

H-acid production issues have been resolved; normalized production and quality expected from Q4 FY2019, leading to improved margins and profits.
Normal EBITDA margins for core chemical business (Vinyl Sulphone and Pigment Green) expected in range of 12%-15%.
H-acid expected to contribute positively to both topline and bottomline from next quarter, likely breakeven at PBT level soon.
Capacity expansions underway:
- CPC Green capacity increased; full utilization expected by end of FY2020.
- Precipitated silica commercial production expected from Q2 FY2020 with revenue contribution starting Q3 FY2020.
- Potential further expansion in Pigment Green subject to market demand.
Effective tax rate higher due to new capital gains tax norms; tax rate expected to be sustainable.
Focus on preserving cash for business expansion, no major tax-saving investments planned.
Demand showing slight improvement starting February; overall cautious outlook but volume growth anticipated.

See what AksharChem (I) management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any current or future fundraising through debt or equity in the provided transcript.
The company is focusing on preserving money within the company for business expansion rather than major investments aimed at tax savings.
Capex plans are primarily related to Greenfield expansion of the H-acid plant (costing around Rs. 55-60 Crores) and further expansion of Pigment Green, depending on market demand.
No firm investment plans beyond existing ongoing projects for FY2020 were indicated.
No explicit references to raising funds via debt or equity were discussed during the call.

Order book

The transcript and presentation from the AksharChem (India) Limited Q3 and 9M FY2019 earnings call does not explicitly mention current or expected order book or pending orders details. However, relevant insights include: - Demand showed some improvement starting February, with the product beginning to "sell itself" compared to previous quarter efforts. - The company anticipates ramping up capacity utilization, especially for H-acid (expected above 50%-60% capacity utilization in Q3) and CPC Green (around 80% utilization of new capacity expected next year). - Expansion plans are on track with new capacities added (H-acid 1,200 MT/annum; CPC Green increased to 2,400 MT/annum). - Demand currently is seasonal and somewhat sluggish due to external market factors like Chinese New Year and overall industry slowdown, but expected to recover. - The company expects operating leverage to improve as capacity ramps up, implying a positive outlook on future orders. No direct orderbook or pending order numbers were disclosed.

See what AksharChem (I) management said on order book — free account, 30 seconds.

Capex plans

Yes

Current ongoing projects:
- Specialty chemical product precipitated silica at Dahej, capacity 10,000 metric tonnes per annum, commercial production expected from Q2 FY2020.
- Pigment Green expansion completed; further expansion planned depending on market demand.
Future capex plans:
- No firm investment plans beyond current projects for FY2020, except for Pigment Green expansion.
- Potential for Greenfield expansion of H-acid capacity estimated to cost around Rs. 55-60 Crores.
Strategy:
- Focus on expanding H-acid capacity if market demand stabilizes.
- Gradual capacity utilization expected for CPC Green expansion over four quarters.
- Emphasis on preserving funds for business expansion rather than major tax-saving investments.

Track AksharChem (I) — get its next earnings analysis in your feed

How does AksharChem (I) rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisAksharChem (I)

Rev 3Mar 3

See where AksharChem (I) sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does AksharChem (I) rank in Chemicals & Petrochemicals?

Compare AksharChem (I) against every Chemicals & Petrochemicals company (Q3 FY19) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What AksharChem (I)'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season

GOCL Corpn. (Q2 FY27)
Year-on-year (YoY) increase in revenue from operations: Approximately 85% increase (41,063 vs. Key results statement takeaways from GOCL Corpn.'s Q2 FY27 result
Bhansali Engineering Polymers Ltd (Q2 FY27)
Revenue from operations (net) for the quarter ended 30/09/2026 is ₹40,336.95 lakhs, compared to ₹32,509.76 lakhs for the quarter ended 30/09/2025, reflecting a…
Tatva Chintan (Q2 FY27)
Q2 FY27 revenue from operations: ₹2,173 Mn, up 76% YoY from ₹1,235 Mn in Q2 FY26 (Page 11). Key investor presentation takeaways from Tatva Chintan's Q2 FY27 inv
Devson Catalyst Ltd (Q1 FY27)
FY 2023-24: ₹5,577.59 Lakhs . Key investor presentation takeaways from Devson Catalyst Ltd's Q1 FY27 investor presentation — and how it ranks against sector pee

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

AksharChem (I) Q3 FY19 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does AksharChem (I) rank in Chemicals & Petrochemicals?

Continue your research

What AksharChem (I)'s management said in earlier quarters

Others in Chemicals & Petrochemicals this season